These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Characterisation and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacter cloacae isolated from a district teaching hospital in Taiwan. Yu WL, Cheng KC, Chi CJ, Chen HE, Chuang YC, Wu LT. Clin Microbiol Infect; 2006 Jun; 12(6):579-82. PubMed ID: 16700709 [Abstract] [Full Text] [Related]
5. Extended double disc synergy testing reveals a low prevalence of extended-spectrum beta-lactamases in Enterobacter spp. in Vienna, Austria. Apfalter P, Assadian O, Daxböck F, Hirschl AM, Rotter ML, Makristathis A. J Antimicrob Chemother; 2007 May; 59(5):854-9. PubMed ID: 17347178 [Abstract] [Full Text] [Related]
6. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007. Jean SS, Lee WS, Bai KJ, Lam C, Hsu CW, Yu KW, Liao CH, Chang FY, Ko WC, Wu JJ, Chen YH, Chen YS, Liu JW, Lu MC, Liu CY, Chen RJ, Hsueh PR. J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410 [Abstract] [Full Text] [Related]
7. Prevalence of extended-spectrum beta-lactamases in isolates of the Enterobacter cloacae complex from German hospitals. Hoffmann H, Stürenburg E, Heesemann J, Roggenkamp A. Clin Microbiol Infect; 2006 Apr; 12(4):322-30. PubMed ID: 16524408 [Abstract] [Full Text] [Related]
8. Occurrence of extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria. Park YJ, Park SY, Oh EJ, Park JJ, Lee KY, Woo GJ, Lee K. Diagn Microbiol Infect Dis; 2005 Apr; 51(4):265-9. PubMed ID: 15808318 [Abstract] [Full Text] [Related]
13. [Phenotypic and genotypic characterization of resistance to third-generation cephalosporins in Enterobacter spp]. Bertona E, Radice M, Rodríguez CH, Barberis C, Vay C, Famiglietti A, Gutkind G. Rev Argent Microbiol; 2005 Apr; 37(4):203-8. PubMed ID: 16502641 [Abstract] [Full Text] [Related]
14. SHV-12 extended spectrum beta-lactamase associated with high-level ceftazidime resistance in Enterobacter cloacae isolated from Thailand. Tansawai U, Boonkerd N, Polwichai P, Dejsirilert S, Niumsup PR. Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):148-54. PubMed ID: 19323047 [Abstract] [Full Text] [Related]
16. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates. Polsfuss S, Bloemberg GV, Giger J, Meyer V, Hombach M. J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269 [Abstract] [Full Text] [Related]
17. Nosocomial outbreak due to extended-spectrum-beta-lactamase- producing Enterobacter cloacae in a cardiothoracic intensive care unit. Manzur A, Tubau F, Pujol M, Calatayud L, Dominguez MA, Peña C, Sora M, Gudiol F, Ariza J. J Clin Microbiol; 2007 Aug; 45(8):2365-9. PubMed ID: 17581932 [Abstract] [Full Text] [Related]
19. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A, Norwegian ESBL Study Group. J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502 [Abstract] [Full Text] [Related]